Key facts
- OneSkin’s last known valuation is $165.0M (Jun 2025).
- It has raised $42.0M across 4 recorded rounds; the latest was Early Stage VC ($20.4M) in May 2025.
- Notable investors include SOSV, Metaplanet Holdings, IndieBio, Able Partners, Unilever Ventures — 13 tracked in total.
- OneSkin has filed 4 Form Ds with the SEC since 2017, most recently Jun 2025 ($20.4M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for OneSkin
Funding rounds
4 roundsAbout OneSkin
Provider of a topical skin supplement intended to target the root causes of skin aging. The company offers vegan supplements, made with ingredients that are suitable for all skin types, help to reduce the skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity, and strengthening the epidermal skin barrier, enabling customers to improve their skin and support proper cell function.
- Industry
- Personal Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 50
- Website
- oneskin.co/
- Ownership
- Privately Held (backing)
OneSkin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OneSkin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OneSkin in its N-PORT filings yet. We sweep new filings monthly.